Nutex Total Assets from 2010 to 2024

NUTX Stock

USD 32.91 1.02 3.20%

Nutex Health Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-03-31

Previous Quarter

422.4 M

Current Value

438.5 M

Quarterly Volatility

228.1 M

Credit Downgrade

Yuan Drop

Covid

Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 26.3 M, Total Revenue of 129 M or Gross Profit of 54.7 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0037 or PTB Ratio of 1.84. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.

Check out the analysis of Nutex Health Correlation against competitors.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Latest Nutex Health's Total Assets Growth Pattern

Below is the plot of the Total Assets of Nutex Health over the last few years. Total assets refers to the total amount of Nutex Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nutex Health books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Nutex Health's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 398.25 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Nutex Total Assets Regression Statistics

	Arithmetic Mean	144,655,519
	Geometric Mean	19,336,098
	Coefficient Of Variation	129.24
	Mean Deviation	168,353,536
	Median	7,637,996
	Standard Deviation	186,952,570
	Sample Variance	34951.3T
	Range	431.3M
	R-Value	0.87
	Mean Square Error	9044.6T
	R-Squared	0.76
	Significance	0.000023
	Slope	36,436,716
	Total Sum of Squares	489317.7T

Nutex Total Assets History

	2024	418.2 M
	2023	398.2 M
	2022	431.8 M
	2021	394.7 M
	2020	308.6 M
	2019	179.2 M
	2018	449.4 K

Other Fundumenentals of Nutex Health

Intangibles To Total Assets

Nutex Health Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Current Deferred Revenue	Common Stock	Short Term Debt	Intangible Assets	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock	Capital Surpluse
Total Assets		0.9	0.97	-0.67	0.95	0.86	0.76	0.98	0.88	-0.51	0.86	0.55	0.67	0.86	0.17	0.72	0.06	0.86	0.03	0.72	-0.55
Total Stockholder Equity	0.9		0.77	-0.35	0.77	0.96	0.47	0.79	0.98	-0.46	0.69	0.45	0.36	0.9	0.43	0.91	0.16	0.92	0.3	0.37	-0.16
Net Debt	0.97	0.77		-0.82	0.96	0.71	0.88	1.0	0.74	-0.5	0.88	0.58	0.81	0.73	-0.04	0.53	0.05	0.71	-0.19	0.85	-0.68
Retained Earnings	-0.67	-0.35	-0.82		-0.82	-0.24	-0.98	-0.81	-0.28	0.3	-0.76	-0.28	-0.99	-0.3	0.53	-0.04	-0.11	-0.29	0.68	-0.95	0.75
Accounts Payable	0.95	0.77	0.96	-0.82		0.68	0.9	0.97	0.72	-0.44	0.96	0.36	0.84	0.77	-0.05	0.55	-0.06	0.74	-0.15	0.87	-0.69
Net Receivables	0.86	0.96	0.71	-0.24	0.68		0.34	0.73	0.99	-0.5	0.57	0.49	0.22	0.93	0.61	0.94	0.21	0.95	0.42	0.3	-0.19
Good Will	0.76	0.47	0.88	-0.98	0.9	0.34		0.87	0.39	-0.33	0.86	0.29	0.99	0.43	-0.44	0.17	0.01	0.4	-0.55	0.97	-0.75
Total Liab	0.98	0.79	1.0	-0.81	0.97	0.73	0.87		0.76	-0.49	0.9	0.55	0.8	0.75	-0.02	0.56	0.04	0.74	-0.16	0.84	-0.66
Total Current Assets	0.88	0.98	0.74	-0.28	0.72	0.99	0.39	0.76		-0.47	0.62	0.47	0.28	0.93	0.54	0.93	0.2	0.95	0.37	0.33	-0.18
Current Deferred Revenue	-0.51	-0.46	-0.5	0.3	-0.44	-0.5	-0.33	-0.49	-0.47		-0.37	-0.42	-0.25	-0.45	-0.18	-0.41	-0.14	-0.46	-0.06	-0.3	0.23
Common Stock	0.86	0.69	0.88	-0.76	0.96	0.57	0.86	0.9	0.62	-0.37		0.24	0.83	0.71	-0.13	0.47	-0.28	0.64	-0.13	0.84	-0.66
Short Term Debt	0.55	0.45	0.58	-0.28	0.36	0.49	0.29	0.55	0.47	-0.42	0.24		0.21	0.28	0.04	0.24	0.13	0.29	-0.05	0.27	-0.2
Intangible Assets	0.67	0.36	0.81	-0.99	0.84	0.22	0.99	0.8	0.28	-0.25	0.83	0.21		0.32	-0.54	0.06	-0.01	0.29	-0.63	0.96	-0.74
Net Tangible Assets	0.86	0.9	0.73	-0.3	0.77	0.93	0.43	0.75	0.93	-0.45	0.71	0.28	0.32		0.59	0.92	-0.03	0.98	0.47	0.44	-0.4
Long Term Debt	0.17	0.43	-0.04	0.53	-0.05	0.61	-0.44	-0.02	0.54	-0.18	-0.13	0.04	-0.54	0.59		0.75	0.12	0.62	0.9	-0.38	0.2
Net Invested Capital	0.72	0.91	0.53	-0.04	0.55	0.94	0.17	0.56	0.93	-0.41	0.47	0.24	0.06	0.92	0.75		0.16	0.96	0.61	0.12	-0.05
Short Long Term Debt	0.06	0.16	0.05	-0.11	-0.06	0.21	0.01	0.04	0.2	-0.14	-0.28	0.13	-0.01	-0.03	0.12	0.16		0.13	-0.28	-0.1	0.25
Net Working Capital	0.86	0.92	0.71	-0.29	0.74	0.95	0.4	0.74	0.95	-0.46	0.64	0.29	0.29	0.98	0.62	0.96	0.13		0.45	0.39	-0.33
Property Plant Equipment	0.03	0.3	-0.19	0.68	-0.15	0.42	-0.55	-0.16	0.37	-0.06	-0.13	-0.05	-0.63	0.47	0.9	0.61	-0.28	0.45		-0.48	0.27
Capital Stock	0.72	0.37	0.85	-0.95	0.87	0.3	0.97	0.84	0.33	-0.3	0.84	0.27	0.96	0.44	-0.38	0.12	-0.1	0.39	-0.48		-0.9
Capital Surpluse	-0.55	-0.16	-0.68	0.75	-0.69	-0.19	-0.75	-0.66	-0.18	0.23	-0.66	-0.2	-0.74	-0.4	0.2	-0.05	0.25	-0.33	0.27	-0.9

Click cells to compare fundamentals

About Nutex Health Financial Statements

Nutex Health investors use historical fundamental indicators, such as Nutex Health's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	398.2 M	418.2 M
Intangibles To Total Assets	0.09	0.09

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC